The Research and Development Team at Lumeda is responsible for advancing the science and technology behind photodynamic therapy (PDT). This multidisciplinary group collaborates on enhancing the DigiLum product, focusing on improving its efficacy through innovative light dosimetry techniques, integrating AI-driven data analysis, and ensuring compliance with quality standards. Their work ultimately supports the development of safer, more effective treatment options for patients battling non-small cell lung cancer and other thoracic malignancies.
View all